Showing results (321-330 of 618) with videos related to
Sort By:
Pageof 62
BMC Cancer|October 30, 2013
SORBS2 and TLR3 induce premature senescence in primary human fibroblasts and keratinocytesMelanie Liesenfeld, Sandy Mosig, Harald Funke, et al.Geburtshilfe Und Frauenheilkunde|June 1, 1988
[Gonadotropin-releasing hormone receptors in human breast cancer tissue]L Kiesel, M Kaufmann, F Haeseler, et al.Anticancer Research|March 1, 1997
Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivativesV J Moebus, R Stein, D G Kieback, et al.Journal of Cancer Research and Clinical Oncology|August 10, 2010
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapyKatharina Pachmann, Oumar Camara, Annika Kohlhase, et al.Human Genetics|June 1, 1994
Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell linesI B Runnebaum, X W Tong, V Moebus, et al.Oncogene|September 11, 2007
Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcriptsN Häfner, C Driesch, M Gajda, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 19, 2009
Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV typesMartina Schmitz, Cornelia Scheungraber, Jörg Herrmann, et al.Human Reproduction (Oxford, England)|February 19, 2009
Treatment of endometriosis of uterosacral ligament and rectum through the vagina: description of a modified techniqueO Camara, J Herrmann, A Egbe, et al.Clinical Epigenetics|November 2, 2017
Performance of a methylation specific real-time PCR assay as a triage test for HPV-positive womenMartina Schmitz, Kristina Wunsch, Heike Hoyer, et al.International Journal of Molecular Sciences|May 14, 2022
Highly Cytotoxic Osmium(II) Compounds and Their Ruthenium(II) Analogues Targeting Ovarian Carcinoma Cell Lines and Evading Cisplatin Resistance MechanismsJana Hildebrandt, Norman Häfner, Daniel Kritsch, et al.Pageof 62